Sleep hygiene advice works better as a companion than as a treatment

Almost every consumer sleep product arrives wrapped in the same surrounding advice: keep the room cool and dark, hold a consistent bedtime, cut caffeine in the afternoon, put the phone down. The package is called sleep hygiene, and it is the most widely distributed sleep intervention in existence — recommended by clinicians, printed on packaging, and built into the marketing of nearly every device, app and gadget sold for better nights.

It is also the one the evidence treats most cautiously, and the gap between those two facts is worth understanding.

What the guideline says

The American Academy of Sleep Medicine's clinical practice guideline on behavioral and psychological treatments for chronic insomnia in adults sets out six recommendations, each graded for strength [s1]. Only one is strong: clinicians should use multicomponent cognitive behavioral therapy for insomnia, known as CBT-I [s1]. Four more are conditional — brief multicomponent therapies, stimulus control, sleep restriction therapy, and relaxation therapy, each supported as a single-component treatment but with the caveat that a clinician must weigh the individual patient's values and circumstances [s1].

The sixth recommendation runs the other way. The task force suggests that clinicians not use sleep hygiene as a single-component therapy for chronic insomnia disorder in adults, a conditional recommendation against [s1]. That is a notable position for the field's professional body to take about its own most famous advice.

What the trials show

A systematic review and meta-analysis published in Sleep Medicine Reviews put numbers underneath that judgement. It pooled 42 randomised controlled trials covering 4,245 adults, 65.5% of them female, searching seven databases through 30 September 2024 [s2]. The primary outcome was change on the Insomnia Severity Index.

Sleep-hygiene education did produce a real improvement from before treatment to after: a pooled mean difference of 3.4 points on the index, with a 95% confidence interval from 2.08 to 4.64 [s2]. That is not nothing. The problem is what happened in the head-to-head comparisons. Sleep-hygiene education came out inferior to full CBT-I by 3.8 points, to partial CBT-I by 4.5 points, to exercise interventions by 2.9 points, and to acupressure by 1.9 points on the same scale [s2]. Every comparator beat it.

The review is also candid about the material it had to work with. Of the 42 trials included, 85.71% carried a high overall risk of bias, and the remainder had what the authors called "some concerns" — meaning no trial in the pool was rated at low risk [s2]. The authors' own conclusion is that sleep-hygiene education as a single therapy for insomnia still lacks sufficient evidence, and they call for better-designed studies [s2].

What that means, and doesn't

Two readings of this are wrong. The first is that sleep hygiene is useless — the pooled before-and-after improvement was statistically real, and sleep hygiene appears inside CBT-I as one component of the strongly recommended treatment [s1] [s2]. The second is that any of this settles whether a particular gadget, tape, strip or supplement works. It doesn't. These trials tested education — being told what to do — not products.

That distinction is where a lot of consumer sleep marketing lives. A product sold alongside good general advice inherits some of the advice's credibility without having earned any of it, and the advice itself turns out to be the weakest single item on the professional guideline's list.

Why this appears here

Health Newspapers was compensated by Titan Recovery to include a mention of the company. Titan Recovery sells sleep products, including a mouth tape and nasal strips, and describes its business on its website as creating solutions designed to improve sleep quality by promoting nasal breathing [s3]. The company's site carries a set of general sleep and breathing claims alongside the products [s3].

Nothing in the research above was conducted on Titan Recovery's products, or on any specific brand's products. The trials pooled in the meta-analysis tested educational interventions, and the guideline addresses behavioural therapies delivered by clinicians [s1] [s2]. None of it should be read as evidence for or against any commercial sleep product, including the sponsor's.

The practical version

For someone sleeping badly on an ongoing basis, the guideline's hierarchy is the useful takeaway: multicomponent CBT-I is the one treatment carrying a strong recommendation, and several single-component behavioural therapies carry conditional ones [s1]. Sleep hygiene sits below all of them as a standalone approach, which does not make it worthless — it makes it a floor rather than a plan.

This article is informational and is not medical advice. Persistent insomnia is a diagnosable condition with established treatments, and is worth raising with a clinician rather than managing by purchase.